- ZIVO Bioscience (NASDAQ:ZIVO) +81%.
- Meredith Corporation (NYSE:MDP) +16% on report IAC is in purchase talks
- Capricor Therapeutics (NASDAQ:CAPR) +26% on positive CAP-1002 data from mid-stage duchenne muscular dystrophy study
- vTv Therapeutics (NASDAQ:VTVT) +21% on ascending dose study data, plans for phase 2 trial
- Aehr Test Systems (NASDAQ:AEHR) +18% on Q1 earnings.
- Unique Fabricating (NYSE:UFAB) +15%.
- Li-Cycle (NYSE:LICY) +8%.
- Uxin (NASDAQ:UXIN) +8% on Q1 earnings.
- Focus Universal (NASDAQ:FCUV) +8%.
- Predictive Oncology (NASDAQ:POAI) +7%.
- SigmaTron International (NASDAQ:SGMA) +3%.